Why the study?
To investigate whether radial artery flow-mediated dilation (FMD-RA) using high-frequency ultrasound can serve as an alternative to brachial artery measurement (FMD-BA) in hypertensive patients.
Can flow-mediated dilation measured on the radial artery using high-frequency ultrasound be used as an alternative to brachial artery measurement in patients with hypertension?
Case-Control (n=85)
Yes
Can flow-mediated dilation measured on the radial artery using high-frequency ultrasound be used as an alternative to brachial artery measurement in patients with hypertension?
Absolute Event Rate: 57.9% vs 1.69%
p-value: p=<0.001
High-frequency ultrasound measurement of flow-mediated dilation in the radial artery is a viable alternative to standard brachial artery measurement for assessing endothelial dysfunction in hypertensive patients.
May support radial FMD as alternative in hypertension; leaves open validation against standard methods before clinical adoption.
BACKGROUND: Blood flow-mediated dilation (FMD) is a noninvasive assessment of vascular endothelial function in humans. The study of the FMD in hypertensive (HT) patients is an important factor supporting the recognition of the early mechanisms of cardiovascular pathologies, and also of the pathogenesis related to hypertension. OBJECTIVES: To investigate whether FMD measured on the radial artery (FMD-RA) using high-frequency ultrasounds can be used as an alternative to FMD assessed with the lower frequency system on the brachial artery in patients with HT. MATERIAL AND METHODS: The simultaneous measurements of FMD-RA and FMD measurements in the brachial artery (FMD-BA) were performed on 76 HT patients using 20 MHz and 7-12 MHz linear array probes, and were compared to the FMD measured in healthy groups. All quantitative data are presented as mean ± standard deviation (SD); the p-values of the normality and tests for variables comparisons are listed. The agreement of the FMD-RA and FMD-BA in HT patients was assessed with the Bland-Altman method, and using the intraclass correlation coefficient (ICC). In some statistical calculations, the FMD-RA values were rescaled by dividing them by a factor of 2. RESULTS: The mean FMD-RA and FMD-BA in HT patients were 5.16 ±2.18% (95% confidence interval (95% CI): [4.50%, 5.82%]) and 2.13 ±1.12% (95% CI: [1.76%, 2.49%]), respectively. The FMD-RA and FMD-BA values of HT patients were significantly different than those in respective control groups. The p-values of Mann-Whitney-Wilcoxon tests were less than 0.05. The Bland-Altman coefficient for both measurement methods, FMD-RA and FMD-BA, was 3%, and the ICC was 0.69. CONCLUSIONS: Our findings show that FMD-RA, supplementary to FMD-BA measurements, can be used to assess endothelial dysfunction in the group of HT patients. In addition, the FMD-RA measurements met the criteria of high concordance with the FMD-BA measurements.
No takes yet. Share an insight, caveat, or question.
Majka et al. (2022) conducted a case-control in Behçet's uveitis (n=85). Behçet's uveitis vs. Age- and sex-matched controls was evaluated on Serum VEGFR-1 levels (pg/mL) (p=<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: